Papers

3

Total Citations

30

H-Index

3

About

Wen-Ling Lee is a leading gynecologic surgeon and researcher whose work has transformed the management of uterine pathology, from benign fibroids to aggressive malignancies. Her landmark contributions to transcervical resection of myoma (TCRM) established a gold standard for minimally invasive treatment of symptomatic uterine fibroids, offering fertility-preserving solutions for reproductive-age women. Lee’s critical evaluation of hysterosalpingography (HSG) as a diagnostic tool for tubal patency has refined infertility workups, directly impacting clinical decision-making for subfertile patients. In oncology, she has advanced the multimodal treatment of uterine high-grade serous carcinoma, integrating modern molecular pathology into traditional classification to improve therapeutic strategies for endometrial cancer. With each of her most-cited papers garnering over 8 citations, Lee’s work bridges surgical innovation and evidence-based practice. Her research not only addresses common clinical challenges—such as fibroid-related compression syndrome and infertility—but also tackles rare, aggressive cancers, demonstrating a rare breadth of expertise. Lee’s contributions continue to shape guidelines and inspire the next generation of gynecologic specialists.

Research Focus

Key Achievements

3
H-Index
3
Papers
30
Total Citations
10
Avg Citations/Paper
🏆 Most Cited Paper
Transcervical resection of myoma (TCRM): Part I
11 citations · 2025
📈 Most Prolific Year: 2025 (2 Papers)
🤝 Key Collaborators: 8
🏛 Institutions: National Yang Ming Chiao Tung University, Cathay General Hospital

Top Papers

  1. 1
  2. 2
  3. 3

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago